Biosketch

Joseph Biskupiak, PhD, MBA

Joseph E. Biskupiak, Ph.D., M.B.A., is a Research Associate Professor in the Dept. of Pharmacy Practice and the Associate Director of the Outcomes Research Center at the College of Pharmacy, University of Utah, SLC, UT.  Dr. Biskupiak’s research interests include health economics, disease management and the U.S. healthcare system. Dr. Biskupiak is a member of the editorial board for Pharmacy and Therapeutics (a peer-reviewed journal for managed care- and hospital-formulary management).

Prior to joining the University of Utah, Dr. Biskupiak was a Director for Strategyx, a pharmaceutical consulting company located in Somerville, New Jersey.  Prior to joining Skila, Dr. Biskupiak was vice president of health services research at Hastings Healthcare Group, Pennington, New Jersey.  In addition, he was a research assistant professor conducting health economics research in the Office of Health Policy and Clinical Outcomes at Thomas Jefferson University Hospital, Philadelphia, PA.  He was also a research scientist and research assistant professor in the Department of Radiology at the University of Washington School of Medicine in Seattle involved in the development of imaging agents for positron emission tomography (PET) and a research investigator in the new drug discovery group at E. R. Squibb and Sons.  Dr. Biskupiak has published widely, particularly in the basic and applied sciences and health services research field.  He contributed the chapters “Disease Management Programs” in the textbook The Role of Pharmacoeconomics in Outcomes Management and “Managed Care Models of Disease Management” in Disease Management: A Systems Approach to Improving Patient Outcomes, both 1996 publications of AHA Press.  He has also written chapters on health assessment tools and changing patient behavior.  He earned a Ph.D. in medicinal chemistry from the University of Utah, an M.B.A. from Seattle University, and a B.S. in chemistry from the University of Connecticut.